Results: AGY
Search articles by EPIC code
views
Allergy Therapeutics – argues “significant clinical progress”, so why the further share price fall?
Allergy Therapeutics (AGY) has issued a trading update for its year ended 30th June 2022 emphasising “effective cost controls implemented alongside the group's significant clinical progress” and “in 2023, sales are expected to return to their previous near double-digit growth levels”. So what of a current share price response to 17p, approaching 7% lower?
- By Steve Moore
- 2022-07-15 16:05:53
NEWSFLOW
Allergy Therapeutics (#AGY) – FY revenue down noting “streamlined portfolio”, upcoming cost increases
- 2022-07-15 07:24:18
views
Despite Posting a Loss, Allergy Therapeutics is Not to Be Sneezed at
Hello Share Puzzlers. Thank goodness the hay fever season is over. I no longer suffer, having moved to the seaside, but the horror of a blocked conk and streaming eyes remains. You may have noticed that allergies seem to be on the rise. At least the number of folk who complain about them is.
- By Malcolm Stacey
- 2016-09-27 00:18:26
NEWSFLOW
Allergy Therapeutics (#AGY) says patient enrolement complete for Phase 2 trial of PQBirch204 drug
- 2015-11-30 00:38:40
views
Zak Mir's Bull Call of the Day No. 2: Allergy Therapeutics: Persistent Trend Towards 45p
It would appear to be that as far as shares of Allergy Therapeutics (AGY) are concerned you do not have to be an expert either on allergies or therapeutics in order to gain exposure to the long side. The movement of the share price is pretty categorical.
- By Zak Mir
- 2015-11-19 02:21:12
views
Zak Mir's Great Request Show: Allergy Therapeutics, Mercom Oil Sands, Tiziana Life Sciences
If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at shares of Allergy Therapeutics (AGY), Mercom Oil Sands (MMO), Tiziana Life Sciences (TILS) and offer some share price targets.
- By Zak Mir
- 2015-09-04 03:34:33
views
Zak Mir's Bull Call Of The Day No.2: Allergy Therapeutics: 40p 2014 Price Channel Target
We have a slightly unusual set up on the daily chart of Allergy Therapeutics (AGY) currently in the sense that the extended basing that the stock has delivered since the turn of the year offered decent range trades within it.
- By Zak Mir
- 2015-07-23 03:48:17
